Theriva Biologics Inc. Common Stock (TOVX)
Stock · AMEX · Health Care
$0.25as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$0.181
Industry
Biotechnology: Pharmaceutical Preparations
About TOVX
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage oncolytic human adenovirus that is in Phase 1 clinical trials and Phase 2 VIRAGE trial for patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian cancer,…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 15
- Website
- therivabio.com/
Fundamentals
- 1-day range
- $0.2431$0.2607
- Market cap
- $10.22M
- P/E (trailing)
- —
- P/E (forward)
- -1.23
- EPS (trailing)
- $-2.50
- Dividend yield
- —
- Beta
- 1.21
- Avg. volume
- 6.19M
- Dividend pay date
- August 13, 2018
52-week range
$0.1628$0.8632
Next earnings: August 14, 2025 · EPS estimate $-0.47confirmed
Forecasts
2 analyst ratings
Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$4
+1500.0%
Median
$2.5
+900.0%
Low
$1
+300.0%
Theriva Biologics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TOVXTheriva Biologics Inc. Common Stock$0.247▼ 1.20%Market cap $10.22MP/E —$0.1628$0.8632
- GDTCCytoMed Therapeutics Limited Ordinary Shares$0.92▼ 4.17%Market cap $9.50MP/E —$0.6801$3.68
- PHIOPhio Pharmaceuticals Corp. Common Stock$1.13▲ 0.45%Market cap $11.97MP/E —$0.8127$4.19
- CNSPCNS Pharmaceuticals Inc. Common Stock$5.52▲ 0.11%Market cap $8.46MP/E —$1.9$10.59
- SNGXSoligenix Inc. Common Stock$0.38▲ 0.00%Market cap $8.22MP/E —$0.28$3.22
- ADILAdial Pharmaceuticals Inc Common Stock$5.6▼ 1.41%Market cap $7.80MP/E —$1.31$249.81
- MTVAMetaVia Inc. Common Stock$1.71▲ 3.01%Market cap $7.64MP/E —$0.9661$19.03
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TOVX Theriva Biologics Inc. Common Stock | $10.22M | — | $0.247 | ▼ 1.20% | $0.1628$0.8632 |
| GDTC CytoMed Therapeutics Limited Ordinary Shares | $9.50M | — | $0.92 | ▼ 4.17% | $0.6801$3.68 |
| PHIO Phio Pharmaceuticals Corp. Common Stock | $11.97M | — | $1.13 | ▲ 0.45% | $0.8127$4.19 |
| CNSP CNS Pharmaceuticals Inc. Common Stock | $8.46M | — | $5.52 | ▲ 0.11% | $1.9$10.59 |
| SNGX Soligenix Inc. Common Stock | $8.22M | — | $0.38 | ▲ 0.00% | $0.28$3.22 |
| ADIL Adial Pharmaceuticals Inc Common Stock | $7.80M | — | $5.6 | ▼ 1.41% | $1.31$249.81 |
| MTVA MetaVia Inc. Common Stock | $7.64M | — | $1.71 | ▲ 3.01% | $0.9661$19.03 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Curious about the stocks that are showing activity after the closing bell on Friday?ChartMill · 8/14/2026
- Theriva Biologics Q2 EPS $(0.07) Misses $(0.05) EstimateBenzinga · 8/11/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 1.72M
- Total value held
- $288.0K
- Institutional holders
- 21
Top holders this quarter
- Unknown450.3K
- Unknown253.2K
- Unknown225.6K
- Unknown192.4K
- Unknown177.0K
- Unknown112.1K
- Unknown105.2K
- Unknown94.6K
- Unknown27.6K
- Unknown23.6K
See the full, filterable feed with live charts on the MarketWall dashboard.